About BinaryMed
At BinaryMed, we give labs and healthcare organisations real-time visibility of their specimens and environments.
Our IoT monitoring solutions deliver reliable data so your team can focus on what matters most – patient outcomes.
Our Story
BinaryMed’s journey began in an unexpected place, the brewing industry. Our sister company, BinaryBeer, pioneered IoT tracking for draught beer kegs.
That same expertise caught the attention of Healius, one of Australia’s largest pathology providers. They approached us with a challenge: could our technology be adapted to track and monitor the transport of pathology samples across their networks?
This pivotal request led to BinaryMed being born to help labs reduce errors, prevent sample spoilage, and gain real-time visibility into their samples as they travel outside the lab. What began as a single adaptation has evolved into a platform that now supports labs and healthcare organisations globally.
Our Mission
At BinaryMed, our mission is to modernise the pre-analytical phase by giving labs and healthcare organisations true visibility into their samples and environments. Too often, this critical stage is vulnerable to blind spots, manual processes, and risks that can lead to errors or spoilage. We believe there’s a better way.
Using IoT technology, we help labs protect patient samples in transit and storage, reduce the risk of pre-analytical errors, and eliminate unnecessary paperwork and manual checks. By automating monitoring and delivering real-time data, we free up staff to focus on critical tasks, the work that drives better patient outcomes.
Modernising the pre-analytical phase with IoT technology that gives labs visibility, protects patient samples, and reduces risk.
Our Global Presence
BinaryMed is headquartered in Australia, with teams on the ground in the UK and Spain. From these hubs, we support laboratories, hospitals, and healthcare organisations across the globe.
Our global footprint means we can work closely with clients in their local context while continuing to scale our impact worldwide.
Our mission at BinaryMed is simple: to eliminate the blind spots in the pre-analytical phase. With IoT and 5G technology, we’re reducing errors, cutting manual processes, and giving labs a modern way to safeguard patient samples.
Who We Work With
Trusted by leading healthcare organisations across the globe.
Eliminate blind spots in the pre-analytical phase.
Our IoT solutions help labs reduce risk, save time, and safeguard every sample.
You guys featured quite heavily in our Pre-Analytical NATA assessment today - in a very positive way. Thanks for all your help to implement the beginning of an improved system for our patients' samples. Your beautiful data made it easy for our auditees to show the auditors our commitment to improved patient care.
Emma Bull QML Pathology